An Engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis
Preprint — published as 10.1039/d4fd00023d
The DOI matches its Crossref record.
Abstract
Messenger RNA (mRNA) therapies have recently gained tremendous traction with the approval of mRNA vaccines for the prevention of SARS-CoV-2 infection. However, manufacturing challenges have complicated large scale mRNA production, which is necessary for the clinical viability of these therapies. Not only can the incorporation of the required 5’ 7-methylguanosine cap analog be inefficient and costly, in vitro transcription (IVT) using wild-type T7 RNA polymerase generates undesirable double-stranded RNA (dsRNA) byproducts that elicit adverse host immune responses and are difficult to remove at large scale. To overcome these challenges, we have engineered a novel RNA polymerase, T7-68, that co-transcriptionally incorporates both di- and tri-nucleotide cap analogs with high efficiency, even at reduced cap analog concentrations. We also demonstrate that IVT products generated with T7-68 have reduced dsRNA content.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“To that end, different studies have shown that using engineered T7 RNAPs with mutation-enhancing termination efficiency can reduce the synthesis of dsRNA byproducts during IVT, offering the possibility of considerably streamlining mRNA manufacturing processes.18,19”
From Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses (2024) · cites this paper as [19]
In the citing paper
“Previous studies demonstrated that the synthesis of sense–antisense RNA molecules can be base-paired with runoff transcripts contributing to the formation of dsRNA byproducts during the IVT reaction.19,32,41”
From Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses (2024) · cites this paper as [19]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
No references could be resolved yet.
Research works printed but not linked: 44
- A.-M. H. Jiao Wei, 2022, The paradigm shift in treatment from Covid-19 to oncology with mRNA vaccines, Cancer Treatment Reviews, 107, 102405, 10.1016/j.ctrv.2022.102405 · DOI · Paper page
- H. M. C. H. Y. H. B. F. A. K. H. A. S. C. P. A. H. A. K. Z. A. K. E. J. A. K. A. L. A. S. R. A. R. H. N. G. A. K. M. A. R. H. B. A. A.-T. Tang P, 2021, BNT162b2 and mRNA-1273 COVID-19 vaccine effectiveness against the SARS-CoV-2 Delta variant in Qatar, Nature Medicine, 27, 2136, 10.1038/s41591-021-01583-4 · DOI · Paper page
- 10.1093/nar/gkw551 · DOI · Paper page
- 2020, The promise of mRNA vaccines: a biotech and industrial, npj Vaccines, 5, 11, 10.1038/s41541-020-0159-8 · DOI · Paper page
- 10.1016/j.omtn.2018.06.010 · DOI · Paper page
- 10.1261/rna.056614.116 · DOI · Paper page
- J. Tate , R. Boldt , B. McFadden , S. D’Costa , N. Lewandowski , A. Shatzer , P. Gollnick and R. Condit , “Biochemical analysis of the multifunctional vaccinia mRNA capping enzyme encoded by a temperature sensitive virus mutant,” Virology, no. 487, pp. 27–40, 2016. · doi:10.1016/j.virol.2015.10.011
- 10.1073/pnas.91.15.6972 · DOI · Paper page
- 10.1093/nar/gkq347 · DOI · Paper page
- 10.1038/nrd4278 · DOI · Paper page
- 2021, Non-Immunotherapy Application of LNP-mRNA: Maximizing Efficacy and Safety, Biomedicines, 9, 530, 10.3390/biomedicines9050530 · DOI · Paper page
- K.. Karikó , H.. Muramatsu , J.. Ludwig and D.. Weissman , “Generating the optimal mRNA for therapy: HPLC purification eliminates immune activation and improves translation of nucleoside-modified, protein-encoding mRNA,” Nucleic Acids Research, vol. 39, no. 21, p. p, 2011. · DOI · Paper page
- 10.1016/j.coi.2020.01.008 · DOI · Paper page
- M.. Baiersdörfer , G.. Boros , H.. Muramatsu , A. J. Mahiny , I.. Vlatkovic , U.. Sahin and K.. Karikó , “A facile method for removal of dsRNA contaminant from in vitro-transcribed mRNA,” Molecular therapy. Nucleic acids, vol., no., p., 2019. · DOI · Paper page
- 10.1261/rna.073858.119 · DOI · Paper page
- 10.1017/S1355838201014078 · doi:10.1017/s1355838201014078
- 10.1261/rna.7380904 · DOI · Paper page
- J. M. A. E. S. C. Henderson, 2021, Cap 1 Messenger RNA Synthesis with Co-transcriptional CleanCap® Analog by In Vitro Transcription, CURRENT PROTOCOLS, 1, e39, 10.1002/cpz1.39 · DOI · Paper page
- 2020, RIG-I-like receptors: their regulation and roles in RNA sensing, Nature Reviews Immunology, 20, 537, 10.1038/s41577-020-0288-3 · DOI · Paper page
- 2021, Modifications in an Emergency: The Role of N1-Methylpseudouridine in COVID-19 Vaccines, ACS central science, 7, 748, 10.1021/acscentsci.1c00197 · DOI · Paper page
- 10.1021/bi000579d · DOI
- 10.1093/nar/gky177 · DOI · Paper page
- 10.1074/jbc.270.11.6298 · DOI · Paper page
- 10.1093/nar/gky796 · DOI · Paper page
- 10.1146/annurev-immunol-042718-041356 · DOI · Paper page
- 10.1093/nar/19.11.2993 · DOI · Paper page
- 2019, RIG-I Recognition of RNA Targets: The Influence of Terminal Base Pair Sequence and Overhangs on Affinity and Signaling, Cell Reports, 29, 3807, 10.1016/j.celrep.2019.11.052 · DOI
- 10.1126/science.1155406 · DOI · Paper page
- 2014, sRNA-activation of TLR3 and RLR signaling: gene induction-dependent and independent effects, Journal of interferon & cytokine research, 34, 427, 10.1089/jir.2014.0034 · DOI
- 10.1093/nar/gkq347 · DOI · Paper page
- S. S. S. W. A. G. C. B. A. J. K. Y. Kim SC, 2022, Modifications of mRNA vaccine structural elements for improving mRNA stability and translation efficiency, Mol Cell Toxicol, 18, 1, 10.1007/s13273-021-00171-4 · DOI · Paper page
- J. K. E. N. D. K. R. T. R. K. P. J. S. J. D. G. M. N. a. J. J. Marcin Warminski, 2021, Structural Insights into the Interaction of Clinically Relevant Phosphorothioate mRNA Cap Analogs with Translation Initiation Factor 4E Reveal Stabilization via Electrostatic Thio-Effect, ACS Chemical Biology, 16, 334, 10.1021/acschembio.0c00864 · DOI
- I. K. M. A. E. Kocmik, 2018, Modified ARCA analogs providing enhanced translational properties of capped mRNAs, CELL CYCLE, 17, 1624, 10.1080/15384101.2018.1486164 · DOI · Paper page
- J. A. R. H. Kern, 1999, Application of a Fed-Batch System To Produce RNA by In Vitro Transcription, BIOTECHNOLOGY PROGRESS, 15, 174, 10.1021/bp990008g · doi:10.1021/bp990008g
- 2021, Synthetic Messenger RNA-Based Vaccines: From Scorn to Hype, VIRUSES, 13, 270, 10.3390/v13020270 · DOI · Paper page
- D. Weismann , N. Pardi , H. Muramatsu and K. Kariko , “HPLC Purification of In Vitro Transcribed Long RNA,” in Synthetic Messenger RNA and Cell Metabolism Modulation, Totowa, N.J., Humana Press, 2013, pp. 43–54. · DOI · Paper page
- L. J. P. G. B. K. M.-M. A. G. P. W. Y. V. D. E. S. S. D. Jelinek I, “TLR3-specific double-stranded RNA oligonucleotide adjuvants induce dendritic cell cross-presentation, CTL responses, and antiviral protection.,” J Immunol, vol. 186, no. 4, pp. 2422–9, J Immunol. · DOI · Paper page
- A. V. a. S. K. A. Dallas, “Principles of Nucleic Acid Cleavage by Metal Ions,” in Nucleic Acids and Molecular Biology, Artificial Nucleases, Berlin, Springer-Verlag, 2004, pp. 61–71. · DOI
- S. Tinar , “The EMA covid-19 data leak, and what it tells us about mRNA instability,” BMJ, vol. 372, p. n627, 2021. · DOI
- 10.1016/j.ymthe.2017.02.005 · DOI · Paper page
- 10.1093/nar/gkr586 · DOI · Paper page
- 10.1038/mt.2008.200 · DOI · Paper page
- “How biomanufacturing can save the world,”, 2021, Nature Biotechnology, 39, 1315, 10.1038/s41587-021-01132-x · doi:10.1038/s41587-021-01132-x
- 10.1126/sciadv.aaz6893 · DOI · Paper page
Cited by
Exploring the Impact of In Vitro-Transcribed mRNA Impurities on Cellular Responses
Camperi, J., Roper, B., Freund, E., Leylek, R., Nissenbaum, A., Galan, C., Caothien, R., Hu, Z., Ko, P., Lee, A., et al. (2024) · Analytical Chemistry · doi:10.1021/acs.analchem.4c04162 · Cited by 22
Metadata
- Authors
- Miller, M., Alvizo, O., Chng, C., Jenne, S., Mayo, M., Mukherjee, A., Sundseth, S., Chintala, A., Penfield, J., Riggins, J., Zhang, X., Sero, A., Dassie, J., Leatherbury, N., Baskerville, S., & Huisman, G.
- Publisher
- openRxiv
- Published
- 2022-09-02
- Cited by
- 11
- References
- 0
- Type
- Preprint
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
How to cite
Cite CoChat for the checks on this page, and the paper for its own findings.
- This page
- CoChat. (2026). Citation check: An Engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis. https://app.cochat.ai/papers/10.1101/2022.09.01.506264
- The paper
- Miller, M., Alvizo, O., Chng, C., Jenne, S., Mayo, M., Mukherjee, A., Sundseth, S., Chintala, A., Penfield, J., Riggins, J., Zhang, X., Sero, A., Dassie, J., Leatherbury, N., Baskerville, S., & Huisman, G. (2022). An Engineered T7 RNA Polymerase for efficient co-transcriptional capping with reduced dsRNA byproducts in mRNA synthesis. https://doi.org/10.1101/2022.09.01.506264
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.